EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins

Laura A Lindsey-Boltz iD, Yanyan Yang iD, Cansu Kose iD, Nazli Deger, Khagani Eynullazada, Hiroaki Kawara, Aziz Sancar iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Laura A Lindsey-Boltz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: DNA Repair, Xeroderma Pigmentosum. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleotide excision repair removes UV-induced DNA damage through two distinct sub-pathways, global repair and transcription-coupled repair (TCR). Numerous studies have shown that in human and other mammalian cell lines that the XPC protein is required for repair of DNA damage from nontranscribed DNA via global repair and the CSB protein is required for repair of lesions from transcribed DNA via TCR. Therefore, it is generally assumed that abrogating both sub-pathways with an XPC−/−/CSB−/− double mutant would eliminate all nucleotide excision repair. Here we describe the construction of three different XPC−/−/CSB−/− human cell lines that, contrary to expectations, perform TCR. The XPC and CSB genes were mutated in cell lines derived from Xeroderma Pigmentosum patients as well as from normal human fibroblasts and repair was analyzed at the whole genome level using the very sensitive XR-seq method. As predicted, XPC−/− cells exhibited only TCR and CSB−/− cells exhibited only global repair. However, the XPC−/−/CSB−/− double mutant cell lines, although having greatly reduced repair, exhibited TCR. Mutating the CSA gene to generate a triple mutant XPC−/−/CSB−/−/CSA−/− cell line eliminated all residual TCR activity. Together, these findings provide new insights into the mechanistic features of mammalian nucleotide excision repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairXeroderma PigmentosumAnimalsHumansDNA DamageCell LineReceptors, Antigen, T-CellUltraviolet RaysMammalsDNA-Binding Proteins

Substanzen

Receptors, Antigen, T-CellXPC protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

ORCID-Profile: Laura A Lindsey-Boltz, Yanyan Yang, Cansu Kose, Aziz Sancar

Förderung

  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Lindsey-Boltz, L. A., Yang, Y., Kose, C., Deger, N., Eynullazada, K., Kawara, H., & Sancar, A. (2023). Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad334

Vancouver

Lindsey-Boltz LA, Yang Y, Kose C, Deger N, Eynullazada K, Kawara H, et al. Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad334

BibTeX
@article{LindseyBoltz2023,
  author = {Lindsey-Boltz, Laura A and Yang, Yanyan and Kose, Cansu and Deger, Nazli and Eynullazada, Khagani and Kawara, Hiroaki and Sancar, Aziz},
  title = {Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad334}
}
Kostenlos starten →